Overview
High-grade endometrial stromal sarcoma (HG-ESS) is a rare and aggressive subtype of uterine sarcoma characterized by rapid growth and high risk of metastasis, primarily affecting postmenopausal women 1.Diagnosis
Histopathological examination with confirmation of cellular atypia and mitotic activity is essential 1.
Immunohistochemistry often shows diffuse CD10 and inhibin positivity, distinguishing ESS from other sarcomas 1.
Grading based on mitotic count and nuclear atypia according to the WHO classification system 1.Management
Surgery: Wide surgical resection (e.g., hysterectomy with adnexectomy and pelvic lymphadenectomy) is the primary treatment 1.
Adjuvant Therapy: Consideration of adjuvant chemotherapy, typically incorporating drugs like doxorubicin and ifosfamide, based on clinical stage and risk factors 1.
Radiation Therapy: May be used in cases with high-risk features or incomplete surgical margins 1.Special Populations
Pregnancy: No specific guidance provided in the abstracts 1.
Pediatrics: Not applicable given the typical age of presentation 1.
Elderly: Management tailored to overall health status and comorbidities; surgical risks need careful evaluation 1.
Comorbidities: Presence of comorbidities influences treatment decisions, particularly regarding surgical feasibility and adjuvant therapy tolerance 1.Key Recommendations
Confirm diagnosis through histopathological examination with immunohistochemical markers (Evidence: Expert opinion) 1.
Perform wide surgical resection as the primary treatment modality (Evidence: Expert opinion) 1.
Consider adjuvant chemotherapy with agents like doxorubicin and ifosfamide for high-risk cases (Evidence: Expert opinion) 1.References
1 Munro MG, Weisberg M, Rubinstein E. Gas and air embolization during hysteroscopic electrosurgical vaporization: comparison of gas generation using bipolar and monopolar electrodes in an experimental model. The Journal of the American Association of Gynecologic Laparoscopists 2001. link60609-3)